| Avera De Smet Memorial Hospital - Cah | |
| 306 Prairie Avenue Sw Post Office Box 160, De Smet, South Dakota 57231 | |
| (605) 854-3329 | |
| Not Available |
| Name | Avera De Smet Memorial Hospital - Cah |
|---|---|
| Type | Critical Access Hospital |
| Location | 306 Prairie Avenue Sw Post Office Box 160, De Smet, South Dakota |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 431332 |
| NPI Number | 1710155460 |
| Organization Name | AVERA QUEEN OF PEACE |
| Doing Business As | AVERA DE SMET MEMORIAL HOSPITAL |
| Address | 306 Prairie Ave Sw, De Smet, SD 57231 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 605-854-3329 |
News Archive
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy.
Patients who go to UPMC Presbyterian for heart catheterization and who receive a stent to treat clogged arteries are now being screened with a simple blood test to determine if they have a gene variant that makes them less likely to respond to a blood-thinning medication commonly prescribed after the procedure.
In health care reform discussions, talk inevitably turns to making hospitals and physicians accountable for patient outcomes. But in a commentary being published in the July 14 issue of the Journal of the American Medical Association, Johns Hopkins patient safety expert Peter Pronovost, M.D., Ph.D., argues that the health care industry doesn't yet have measurable, achievable and routine ways to prevent patient harm — and that, in many cases, there are too many barriers in the way to attain them.
Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.
Neuroblastoma, a rare childhood cancer of the sympathetic nervous system, is particularly deadly because it is difficult to detect and thus generally advanced before treatment begins.
› Verified 6 days ago
| NPI Number | 1841271186 |
| Organization Name | HURON REGIONAL MEDICAL CENTER |
| Doing Business As | DESMET MEMORIAL HOSPITAL |
| Address | 306 Prairie Ave Sw, De Smet, SD 57231 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 605-854-3329 |
News Archive
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy.
Patients who go to UPMC Presbyterian for heart catheterization and who receive a stent to treat clogged arteries are now being screened with a simple blood test to determine if they have a gene variant that makes them less likely to respond to a blood-thinning medication commonly prescribed after the procedure.
In health care reform discussions, talk inevitably turns to making hospitals and physicians accountable for patient outcomes. But in a commentary being published in the July 14 issue of the Journal of the American Medical Association, Johns Hopkins patient safety expert Peter Pronovost, M.D., Ph.D., argues that the health care industry doesn't yet have measurable, achievable and routine ways to prevent patient harm — and that, in many cases, there are too many barriers in the way to attain them.
Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.
Neuroblastoma, a rare childhood cancer of the sympathetic nervous system, is particularly deadly because it is difficult to detect and thus generally advanced before treatment begins.
› Verified 6 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy.
Patients who go to UPMC Presbyterian for heart catheterization and who receive a stent to treat clogged arteries are now being screened with a simple blood test to determine if they have a gene variant that makes them less likely to respond to a blood-thinning medication commonly prescribed after the procedure.
In health care reform discussions, talk inevitably turns to making hospitals and physicians accountable for patient outcomes. But in a commentary being published in the July 14 issue of the Journal of the American Medical Association, Johns Hopkins patient safety expert Peter Pronovost, M.D., Ph.D., argues that the health care industry doesn't yet have measurable, achievable and routine ways to prevent patient harm — and that, in many cases, there are too many barriers in the way to attain them.
Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.
Neuroblastoma, a rare childhood cancer of the sympathetic nervous system, is particularly deadly because it is difficult to detect and thus generally advanced before treatment begins.
› Verified 6 days ago
Avera De Smet Memorial Hospital - Cah Critical Access Hospital Location: 306 Prairie Avenue Sw Post Office Box 160, De Smet, South Dakota 57231 Phone: (605) 854-3329 |